The deal is expected to be completed by the end of Q3 2023, contingent on regulatory approvals and other closing conditions.
Spectrum is a well-known company in the advanced manufacturing of specialty medical devices and components.
The acquisition is likely to strengthen DuPont’s position in healthcare markets with low cyclicality.
The company is anticipated to earn about 10% of its consolidated revenue from healthcare following the acquisition.
AEA Investors LP is a private equity firm managing $19 billion of invested and committed capital.
DuPont is a global innovation leader offering technology-based materials and solutions that transform industries and everyday life.